← Back to headlines
Aclaris Therapeutics Q4 Earnings Report
Aclaris Therapeutics reported a GAAP EPS of -$0.16, missing estimates, and its revenue of $1.3M also fell short of expectations.
26 Feb, 12:41 — 26 Feb, 12:41
ℹOnly 1 source covers this story
